Netlink Solns(I) (509040)

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Price-to-book of 1.15 against book value of ₹123.18 provides a limited downside cushion if assets are real.
• ROCE of 20.45% suggests the underlying operating capital can earn a decent return even though ROE is weak.
• Piotroski F-Score of 6/9 indicates moderately healthy financials on balance-sheet metrics.
• Reported profit growth of 164.47% hints at a possible earnings rebound, though from a tiny base.
• Market cap of ₹36 crore and price near the lower end of its 52-week range make it a potential low-expectation asset situation.

Concerns

• Extreme P/E of 461.10 with 0% sales growth and latest quarter sales and net profit at ₹0 crore makes fundamental valuation impossible.
• ROE of just 0.31% shows the book value is currently earning almost nothing for equity shareholders.
• Zero dividend yield means minority shareholders receive no cash return while waiting for a recovery.
• Promoter holding is not disclosed, leaving a critical governance and skin-in-the-game question unanswered.

AI Analysis

At ₹142.20, Netlink Solns is a ₹36 crore microcap in software products. Benjamin Graham taught me to buy a business with a margin of safety. The first line of safety is here: the stock trades at only 1.15 times book value, about 15% above a book value of ₹123.18. That is not expensive on the balance sheet. But I don't buy assets; I buy earnings power. That is where my discipline stalls. The P/E is 461.10, sales growth is 0.00%, and the latest quarter shows zero sales and zero net profit. You cannot justify a 461 P/E with no current revenue and no dividend. The reported 164.47% profit growth is mathematically impressive but economically meaningless when the base is negligible. A 0.31% ROE says the book value is earning almost nothing for shareholders. The 20.45% ROCE does not comfort me because it is not flowing through to equity returns in this frame. The Piotroski F-score of 6/9 is moderate, but not a verdict. With promoter holding unknown and insufficient data, I cannot trust the transparency. This looks like an asset-backed option or a potential turnaround, not a compounder. I would want to see real sales and profits return before deploying capital. If management can turn that book value into consistent earnings, this could be interesting. But Graham's rule is to be certain before yielding. I am not certain.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer